Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BREAKING NEWS!!!!!!!!!!!!!!!!!!!!!!
RECAF CAN DETECT CANCER WITH HIGH SPECIFICITY A SENSITIVITY WITH A SMALL DROP OF SALIVA!!!
What other marker can do all that recaf has been proven to accomplish.
Again I ask why haven't the other markers succeeded?
THEY DON"T HAVE DR MORO!!!!!!
"Stating that a broad spectrum cancer marker is a negative thing is akin to stating that using a thermometer is not good because if you have a fever it does not tell you where the infection is."
And what is your response?
Inverness has paid so far $1M for rights to the RECAF tests and the project has a very high level of priory within their organization.
And what is your response?
The ELISA format will be commercialized directly by the company via smaller labs in other countries. We are well advanced in this initiative.
And what is your response?
We’ll be talking to a number of research and clinical labs at ISBM 2008 and we expect to arrange several collaborations using the ELISA format.
GS, are you nervous about our upcoming presentation at the upcoming ISOBM? And what is your response?
Let's see you start backpeddling right about now!
After reading the responses by Dr Moro it dawned on me that all the negativity is to create a MUCH lower share price for private placements which he said is going on right now. At this price every minute creating doubt would allow someone to get shares 7% less for every .01 of downside. Nice work!!! GreatGrandma you got spooked as well as many others. On the bright side, you will remain healthier and live longer as a result of Recaf being commercialized.
I will no longer tolerate the abuses of the past weeks. I will retort your personal deceptions. I as well as other investors, will, and should respond and share their ideas on how recaf will succeed and go on to benefit all of us. I am sure the debate will ensue after posting Dr Moro's responses.
Message from Dr Moro:
The following are questions that have been posted to this discussion board recently and answered by Dr. Moro. Neither the questions, nor the answers were edited by AGORACOM.
Your detailed discussion of the C/N ratio was very informative. I think I understand it now, but was just wondering ... is it analogous to the Signal/Noise ratio used in electronics?
No. In electronics there is noise coming from different sources. For example, in radio waves you have static produced more or less at random by other radio sources (including lightning in electric storms which cover a broad spectrum). You also have thermal noise, which is produced in a wire or a transistor conducting electricity. In immuno-assays such as ours, there is also “noise” which comes in the form of non-specific binding of the labeled molecule (RECAF in our case) to the plastic of the container where the reaction takes place. This noise is irrelevant because the measurements are “ratiometric”, that is, the reading of a sample is compared to the readings of a set of standards of known concentration and the value is extrapolated from the “standard curve” obtained with those standards.
As happens with all other biological markers, normal people have some RECAF in circulation –it is not noise, it is actual RECAF- and cancer people have more. The C/N ratio is the average of the RECAF values in cancer patients over the average of RECAF values in normal individuals in a given set of samples. If there is too much background (which is what happened in the poster presented in 2007 along with Abbott), the C/N is reduced (suppose the normal average = 3,000 Units and the cancer average = 6,000 Units. You would have a C/N=2. However, if there were 2,000 Units of background (or noise) then the normal average = 5,000 and the cancer average = 8,000. Thus the C/N ratio = 1.6. In terms of discrimination, however, it makes no difference because the noise is constant. The solution (which has already been attained) is to reduce the background.
I am looking at this situation as an outsider and you would garner tremendous clout and a major boost in confidence if you would get Abbott or Inverness to begin to acknowledge Recaf. It is bizarre as a shareholder to never reference Recaf on their websites. Will we ever see us on their websites and spoken openly and not treated as though we are a top secret experiment?
I appreciate this comment but that is not how they operate. In addition, it is not in their best interest to promote a technology they have not yet introduced in the market because while that might draw the attention of competitors, it offers no benefit to them.
Question: How do you see the future of cancer diagnostics?
IMO this is how I view it but what is the perception of the industry?
The ultimate patient's questions about cancer.
Do I have it?
What type is it?
Where is it located?
Can it be removed?
Is it gone yet?
Has it returned?
Healthcare (in or out of the hospital) follows a mode of operation. They start with a general assesment and narrow in on the root cause. Recaf may be used first to screen the general population to test for the presence of any type cancer.
Keep in mind that 1 in 3 people will develop cancer in a lifetime. That also means that 2 in 3 will not get cancer. This negative group in the US. population is equal to about 220 million people assuming our population is 360 million. This same assumption means that 1 billion Chinese will be effected but 2 billion will not.
It would be very expensive for the insurance companies to test each person with a pallet of say 20 types of biomarkers specific to only one type of cancer.
I see an industry that will start with a Recaf to separate Cancerous persons from non cancerous persons. Those with cancer will then be exposed to a pallet of cancer specific biomarkers and or scanned to internally locate it.
This multi pallet would most likely contain many biomarkers such as Recaf, EPCA-?, CEA and other highly sensitive markers we have not even heard of yet.
The scan will be "X" and will need to show where it is, if it is operable or if it has been reduced in size. Ultimately the scan will assist in the destruction of the cancer via some type of delivery device.
The bottom line is the only markers that will not be used are those that cannot keep pace with the new ones coming out. I would assume that the Area under the curve (AUC) results will determine this answer. As it stands now, Biocurex has a tremendous front line of tools.
That pretty much sums it up.
I would like to know if we are currently talking with any major cancer institutions, research centers, hospitals, or universities about our ELISA test or are you waiting for the ISOBM? Competition is healthy and expected with any product or service, but do you see any threats with any of the competing markers. This needs clarification. My belief is that we are unique in that it is a universal cancer marker. Isn't that what sets us apart from the competition? Wouldn't that make us the only test sensitive enough to become the only rapid test brought to the market? Thanks for creating this more civil environment and allowing for proper communications with your shareholders.
<!--[if !supportLists]-->1) <!--[endif]-->We’ll be talking to a number of research and clinical labs at ISBM 2008 and we expect to arrange several collaborations using the ELISA format.
<!--[if !supportLists]-->2) <!--[endif]-->The ELISA format will be commercialized directly by the company via smaller labs in other countries. We are well advanced in this initiative.
<!--[if !supportLists]-->3) <!--[endif]-->The ELISA format and the rapid tests are different things: The ELISA test is for clinical labs, it takes 3 hours to be done and it measures the amount of RECAF in serum with high precision. The rapid test is a qualitative test (yes/no), it is not as accurate, it can be done in a doctor’s office or a drug store for that matter and it takes less than 5 minutes. It requires a drop of blood taken from a finger.
<!--[if !supportLists]-->4) <!--[endif]-->The rapid tests should not cannibalize the clinical tests because they are not as accurate: Once a rapid test shows positive, RECAF needs to be measured and that requires a clinical assay, the same way a rapid pregnancy test is followed by a clinical test measuring HCG.
Dear Dr. Moro,
I have been a BOCX shareholder since 2003. You are right about the reason people are questioning BOCX investment is b/c of the 70% drop in shareprice in the last 3 months. I also own other investments (good companies) that also have touched 5 yr lows in shareprice and continue to hold to weather the storm.
My questions regarding BOCX are as follows:
1) How long do you expect the CASH that BOCX has on hand to last? (6 months?, 1 yr?)
We are entertaining and examining a number of private placements against restricted stock and we are confident that we’ll have them in place before we exhaust our funds.
We noticed a question from someone interested in making a private placement. We have been taking private placements since 2003 and therefore we would like to ask everyone interested in making one to contact us directly at (604) 207 9150. During my absence next week, Ms. Bold-de-Haughton will be able to provide information on the subject.
2) How will BOCX pay off the $3M it owes to Smithline next year? (cash infusion by 3rd licencee? revenues from Elisa test? Share dilution?)
The loans are now at $1.7M, not $3M. Whether we continue paying with cash or stock will depend on the market conditions, the amounts to be received from new licenses, revenues, private placements, etc.
3) In your opinion, is the fact that RECAF is a UNIVERSAL CANCER MARKER a positive or negative feature? Some people think it is a negative b/c recaf can only say if cancer is present and not WHERE it is in the body? Other's think it is a positive b/c other markers (PSA etc) only detect one type of cancer.
I have discussed this topic extensively in a previous response. Most of what I wrote was ignored by those interested in bashing the company. For example, I started by providing several examples – such as monitoring disease or monitoring therapy efficiency – in which having a single marker is much more practical than having a battery of them and where the site of the tumor is already know and therefore the argument is void. The size of the market for follow up, monitoring therapy and determining if a lump is malignant or benign is very large.
Stating that a broad spectrum cancer marker is a negative thing is akin to stating that using a thermometer is not good because if you have a fever it does not tell you where the infection is.
Finally, I made a legal argument: What would you do if you knew that there is a cancer marker available that was not used on you in your last clinical checkup because it cannot tell the source of the tumor (and therefore it would force spending money to confirm it and find the location) and now your cancer is so advanced that your chances of survival are very low? Assume for this mind experiment that you were among the 90% of cancer patients who are RECAF positive. It is likely that you would sue for malpractice. Now think of your reaction if after a RECAF test you are told you might have cancer and that further tests are required to discard that possibility. The tests are done (even at your own cost) and you are told it was a false alarm. Are you going to sue for mental distress or are you going to feel very relieved?
Has Biocurex considered investigating--or has ruminated on any postulates for investigating--why some cancers do not express RECAF?
While this is a very interesting question, it is to be answer in the realm of a pure research lab; our priority now is to take product to market and make money for our shareholders.
Is there anything about the origin and/or function of RECAF that tells us something new about cancer? Could this point to a possible adjunct test for early detection of "non-RECAF-cancer"?
I do not know the answer to this question and I am afraid the subject is too vast to speculate.
Is Biocurex aware of any research elsewhere that is studying this aspect?
No.
Dr. Moro,
The agreement with Inverness calls for quarterly summary reports to describe the progress of development. Assuming that these reports are being received from Inverness can you please update the shareholders on the progress made by Inverness to date?
Thank You.
7.3 Reports. Within ninety (90) days following the end of each quarter
during the term of this Agreement, Inverness shall prepare and deliver to
BioCurex a written summary report which shall describe (a) the research
performed to date employing the Licensed Materials and Technology, (b) the
progress of the development, and testing of Products in clinical trials, and (c)
the status of obtaining regulatory approvals to market Products.
Unfortunately we are under non-disclosure clauses and therefore all I can say at this point is that we are satisfied with the progress taking place. Inverness has paid so far $1M for rights to the RECAF tests and the project has a very high level of priory within their organization.
I am not sure if this will help us because we are not on a major exchange. Notice no comments or acknowledgement on the recent patent on THERAPEUTICS from the peanut gallery at IHub. Dr Moro, there is obvious manipulation of the share price to keep the price under .30 cents (that seems to be the magic number). I have seen that shares are sold below the ask all day long and they just reload to make sure the price does not rise. I know that you have addressed shareholders, and that you are aware of this, but your only solution is to pay off the loan. Do you see this being resolved before the end of this year? It would give any current or future shareholders more of a reason to add to their position.
We have noticed some unusual trading patterns but we cannot attribute them to any specific group or interest. We intend to pay off the loan as quickly as possible, with as little as possible dilution all the while keeping the company liquid. This is a balancing act that we have been able to maintain for the past 5 years and we plan on continue our policy even during the current very adverse market conditions
Are their three different Therapeutic Appications of (Anti Recaf) ? One for each of the AFP-L1,AFP-L2,AFP-L3. Or is one good for all three?Please explain Therapeutic Appications if your allowed to at this time. Thank you Dr.
AFP-L1 and RECAF have nothing to do with each other. AFP is a protein that binds to RECAF. They are 2 different substances. The L1, L2, etc are variants of the sugars AFP has attached. They have nothing to do with the sugars attached to RECAF. RECAF does not see a sugar; RECAF has a sugar that binds to AFP. Approximately 50% of ALL proteins have sugars attached.
Do you see Biocurex hiring key employess in the next three months to help with areas such as finance, sales and marketing, product development, to name a few, so you can free yourself to manage the more critical areas of Biocurex that need your expertise rather than managing all areas of the company as you do now.
Finance, sales and marketing ARE the most critical areas of BioCurex and that is where the CEO has to be involved with. As we move forward, we’ll need more people in sales and marketing and we’ll hire them as needed. However, it is worth noting that many companies are reducing their personnel in order to curtail costs.
Company: BioCurex
From: newbie21
Title: NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS
Body:
In this section of the lastest filing, you state your intentions to restructure the convertible notes payable into common stock. Do you still intend to convert the 1.9 million currently due into common stock?
The decision to convert or pay in cash depends on many circumstances such as share price, market conditions, funds availability and it needs to be made each month. So far, the company has paid in cash. The company is advancing on a number of fronts to secure funds. Some of these require no dilution or minimal dilution and they will eventually determine how the convertible notes are paid. The details of these deals cannot be disclosed at this time. It should be noted that since 2003, when Moro became CEO, to present, the company has never had a situation in which it could not meet its financial obligations.
Company: BioCurex
From: newbie21
Title: 416% effective interest rate
Body:
You have not responded to the accuracy of the effective interest rate of the loan being 416% so I suppose it is correct. Why did the company borrow 3 million at such a high effective interest rate and then just use the money to pay off the loan? If my figures are correct, the 3 million will be gone by the end of the year with about 1.5 million still owed. Why didn't the company just sell stock instead?
The 416% is an accounting atrocity emerging from the Black-Shole Pricng Model calculations introduced in the regulations to punish small issuers like us for the excesses of Enron and their kin. It can be tracked back to the S-1/A registration of 2008-04-28 (http://sec.gov/Archives/edgar/data/1... ) and it has to do with the arcane way of accounting for the warrants, etc. It is an atrocity because if we pay the notes with cash, the actual interest rate would be about 30% to 40% over the entire period. It is also an attack on common sense which dictates that an option or a warrant is NOT a loss until it is exercised. At least, one would expect that if a warrant is accounted as a loss, if it expires without being exercised, the loss would be recovered. That is not the case.
In closing, there is a great deal of unwarranted speculation about the future of our company, our ability to finance it and the commercialization of our technology. There is fear emerging from the general market conditions and from the systematic and repetitive comments of some individuals who have made a point in bashing us. That has driven the stock price down to levels that do not represent the price average of the past 2 years, that do not represent the unusual feat for a small company to be able to generate licensing agreements with two industry giants so far and more to come. Our current stock price does not represent the value of its technology or the fact that Abbott presented results at an international congress validating our own results. It does not represent the value of the accumulated investment that has resulted in a unique technology that can literally save lives and make BioCurex’ shareholders a significant profit in the process, as has already being the case several times before in our history.
Fear will pass; it always does because it relates to a negative emotion that feeds on itself rather than to reality and things will then come back to normal. A summary look at what this company has achieved with less than $10M in total cash investment gives an idea of our reality
He answered EVERYTHING. NO HOLDS BARRED. In other words he was truthful and did not dance around the pressing issues.
Why would you want a recaf test? There are many reasons and here a few:
1)Patients with chronic liver diseases such as cirrhosis or chronic hepatitis B must be monitored at regular intervals because they have a lifetime risk of developing liver cancer. A doctor may order a recaf test, along with imaging studies, to try to detect liver cancer when it is in its earliest, and most treatable stages. If a patient has been diagnosed with hepatocellular carcinoma or another form of cancer, a recaf test may be ordered periodically to help monitor a patient’s response to therapy. AFP decreases when your body responds to anti-cancer therapy. If AFP does not return to normal within about one month after cancer therapy, some of the tumor may still be present. It is imperative to have absolute assurance and be monitored EFFECTIVELY.
2)Screening with recaf refers to looking for cancer in people who have no symptoms of the disease. Early detection is finding cancer at an early stage, when it is less likely to have spread and is more likely to respond well to treatment.
3)Some types of cancer grow and spread faster than other types(such as breast cancer).
4)One of the most important uses for recaf is to monitor patients being treated for cancer, especially advanced cancer. Using recaf it is much easier to measure it to see if the treatment is working rather than repeating chest x-rays, CT scans, bone scans, or other tests. It also tends to be less expensive.
5)If the tumor marker level in the blood goes down, it is almost always a sign that the treatment is having an effect. On the other hand, if the marker level goes up, then the treatment probably should be changed. It will give doctors a roadmap and send a signal that they need to change the course of treatment possibly adjusting to a more agressive therapy.
6)Women who have been treated for breast cancer should have yearly blood tests for levels of recaf. This can sometimes detect cancer recurrence before the woman has symptoms or evidence of cancer on imaging tests.
I could go on and on and this will obviously upset the apple cart for the individuals that have sadly succeeding in creating doubt.
There are so many uses for recaf that I have to stop your ranting. If you or I know your geneology or family's medical history you or I may be predisposed to CERTAIN cancers and I would absolutely want a Recaf test. This is such an old argument but recaf has now has the ability to detect cancer EARLY and imaging will find the cancer but also common sense would lead you to a particular cancer given one's family history. The most exciting aspect is curing cancer which can only can only be done by finding a universal marker.
To be continued...............
No else has Dr Moro. He has explicit knowledge on the intracacies of AFP and Recaf. Apparently they don't. You think that all of Dr Moro's accomplishments happened by shear luck?
I want everyone to know many of my posts have been deleted because they are used to having a one sided discussion and they don't want to play chess with me, they have their own set of rules. Freedom of speech is the only reason why this board exists and you have had your fun, but the clock is ticking.
You are also forgetting the most important aspect to finding a universal cancer marker. FINDING A CURE FOR ALL CANCERS. I let you ram the negatives down everyone's throat and you will be lucky if the longterm investors never find out your real name. IMO, they are about to be very upset.
You are totally focused on diagnosing cancer and Dr Moro is totally focused on finding a cure. We will see who is right.
YOU have bamboozled many unsuspecting shareholders. Shame on you. No names or aliases need to be mentioned. I think everyone knows who I am referring to.
These are only in the UShttp://www.freepatentsonline.com/y2007/0237760.html?query=ricardo+moro&stemming=on
http://www.freepatentsonline.com/y2004/0086455.html?query=ricardo+moro&stemming=on
http://www.freepatentsonline.com/6514685.html?query=ricardo+moro&stemming=on
http://www.freepatentsonline.com/y2002/0110556.html?query=ricardo+moro&stemming=on
http://www.freepatentsonline.com/y2008/0133141.html?query=Abbott+recaf&stemming=on
http://www.freepatentsonline.com/y2007/0178504.html?query=Abbott+recaf&stemming=on
http://www.freepatentsonline.com/y2008/0160546.html?query=Abbott+recaf&stemming=on
Look at highlighted areas you will see Recaf and Biocurex
ABBOTT has included us in the patent ........
We are of no use to Abbott? They have presentated data along side of us at the ISOBM..........WRONG
The results for ovarian cancer using Serum-RECAF show a sensitivity of 90% with 95% specificity. The current marker of choice for ovarian cancer is CA-125 and it has a sensitivity of only 77% compared with the 90% found with Serum-RECAF.
It makes no sense that you insist recaf has no value. I beg to differ and clearly see it at face value for what is worth. Everyone knows you have one mission. Destroy Biocurex. Now debate that!
You are wrong and are only a lay person with a vendetta. This has been apparent for quite some time but I expect a great ISOBM in about one week, so enjoy your last jabs.
Since you feel compelled to destroy something that has worth to all of mankind and you are so negative I will share my thoughts and back them with facts unlike your "theories."
Sorry to burst your bubble but we do have 2 licenses. Again you are dismissing facts.
Diagnosis of certain types of cancers such as brain and lung cancer, a biopsy is not feasible, therefore a marker such as recaf has tremendous value. That is just one of many examples where recaf can and will be utilized.
Abbott and Inverness see recaf as a viable tool. Don't listen to Goldseeker. He speaks as though HE decides what is best for modern medicine. He is not a doctor nor has he had any clinical or research background in cancer. He can find information which is biased in either side of the issue. He chooses reasons to speak poorly of this "miracle protein" as described by Dr Steward Sell. You may as well ask the mailman or your dog groomer whether there is any value to recaf. I am sorry for those that fell prey to his shennanigans.
Your little "hobby" is most likely to be put to rest. Have your list of positives ready so you can continue to post because you will have to cover your tracks when all of your theories are invalid. All of your posts will come back to haunt you and there will be quite a few upset shareholders. The tide is about to turn. You still have a few days to rattle some more cages. Enjoy.
Just my opinion.
GS and your many aliases did plenty of damage and destroyed many longterm shareholders and all I can say is you have also created an opportunity for others. Start the countdown. I and everyone else you have taunted will deserve and expect an apology when this is done in the next few days.
I am sure you would never post this because it is about to blow up in your face.
Someone asked management if there was a gag order in effect?
Response..........................
There is no gag order. However, if someone was to make a significant announcement at the conference, they would probably want to keep it quiet until they made their presentation at the conference for maximum effect. In essence, a gag order that was self imposed.
Let's see if you can give everyone a reason for not posting this here. You are supposed to be unbiased.
You will have some explaining to do and I would say it is time to cover your shorts. Good luck when there is no more sellers.
There will be justice in the end. Opportunity Knocking.
1)I am not one of the original (80) investors.
2)I frequently called BioCurex when I had the urge. (When Terry was there and did his best). For quite some time they answered the phone and I tried to purge as much information as possible without crossing the line.
3)I am a long term investor in BioCurex and I WAS here, soon to be past tense, because until recently, I felt we were in need of better communication by management. Now we have Agora (best move Dr Moro could have done). Soon this website will be obsolete, because the only meaningful information will be discussed at Agora.
4)I feel duped by the people on this board that I had once thought of as compadres, but IMO they have ulterior motives.
5)I noticed that TODAY both Kag and TedF are now PAID subscribers. Now why would they do this? Because now they can privately post to one another, and also they start their routine early in the morning and run out of free posts.
5)2 things I will leave here saying....First, everyone here agrees Recaf works. Second, I find Dr Moro to be an honorable man. I apologize if I am wrong about the 4 Amigos, but I am a seasoned investor and this just got too out of hand.
6)The smack down is over for me. I will no longer be a part of this board. I'll hang at the new sanctuary where it is more civil. The 4 of you, at least enjoy your weekend. This is too much like a job and I am (nor is anyone else) no longer benefiting from the conversation here.
4 Amigos, why do you spend 18 hours a day posting on this chatroom and keep a close eye on EXACTLY how many shares traded and EXACTLY at what price if you don't own shares. It is disturbing. It is time for a reality check. Is that normal behavior?
Who's fooling who? Your cover has been blown and it is time for a new identity. Think about taking some time off, and regrouping, and maybe by then, with a new name, you can try to start the cycle again. Good luck. No one should base their investment decisions EVER by small talk in a chatroom.
I must make the assumption that you lost money so it is your life's mission to destroy a company whose life's mission is to diagnose and cure cancer. You are a wonderful person. Good luck in your endeavors.
Unequivocally no relations. No friendships. Strictly an investment.
If you don't stop saying Abbott returned the license you can rest assure Dr Moro will put an end to this charade legally!!! It is not difficult to trace your IP adress and you may find the SEC at your doorstep for spreading false rumors.
Dr Moro wrote, "There is a confusion between ELISA and manual tests in reference to the Abbott license: All tests, with the exception of radioimmunoassay (RIA) are licensed to Abbott."
LICENSED TO ABBOTT!!!
Where's the doom and gloom about us losing the licensing agreement. You were adamant that they had returned the license. You put your credibility on the line and it was a complete fabrication and the "REAL SHAREHOLDERS" have reason to bring you up to the SEC. Why is it your life's mission to destroy a company that will bring so much good to this world. That is my motivation to post here and stop the lies.
I propose we focus on what good will come from the commercialization of recaf. You guys have your ulterior motives, but at least I can sleep at night making an honest living. I believe in Karma.
I asked the 4 of you to ask your questions directly to Dr Moro at Agora.com and none of you have. That is the truth. If you are so concerned for OUR money stop asking questions to unknown individuals in a chatroom which should not speak on behalf of Dr Moro. An example of manipulation is someone willing to sell a pittance of shares 5000@.26 =1300.00 or lower in order to create doubt and fear. I know that this the year, finally, that there will be cause for celebration. Do you think he brainwashed his lab employees to stick around if they thought they were about to lose their jobs and their stock. It did not and will not happen.
You can guarantee that one of the 4 Amigos will attempt to spin Dakota's post that quotes Dr Moro. Get ready for some dung.
Dakota, thank you for the posting the TRUTH! That is the only credible thing stated here in quite some time. If by chance there are skeptical shareholders reading this board we have an obligation to bring forth the only information that has true meaning.
Hey 4 Amigos, you want a more likely scenario? Inverness gets bought. I believe so strongly in Recaf that I hedged my bets by owning shares in Abbott, Inverness, and BioCurex. You guys can speculate about this and that, but one thing we ALL agree on is that this is extraordinary technology and whomever ends up with it will get huge returns on their investment.
Gaboy, you may be correct in your thought that this is perpetrated to lower the share price so they can buy at these ridiculous prices. Why would Gold sell at .18 cents. At that point, even at today's share price for that matter, you would have to be desperate and in immediate need to access your money. Not one intelligent person wouldn't call this is a speculative stock, so why panic?
If it doesn't fit........ it's not legit!
Gold, I couldn't tell you what I have in my own bank acct let alone write a response to these questions lickity split and spout out numbers and fine print in agreements. You may be blowing your cover.
Gold there is definitely something fishy going on. You had a reponse way too fast to our question as if you were prepared for the topic and you keep talking about takeovers in a recent post. We will dub you Gold Fish, because there is something fishy about your endless hours of posting, and you sold out. GG, I posted the question.
I can assure you they haven't sold and have no immediate plans of selling (the stock and most definitely the company). However, I wonder about the poison pill and I will pose the question at Agora. Joe or any "REAL SHAREHOLDERS", do you have anything that I can ask on your behalf to clear up any of your concerns? I think most everyone's anxiety was put to rest in the last week or so, but it is important to not let management think they deserve any free passes. The second any of us get that anxious feeling again we should immediately jump over to Agora and set the record straight.
I must inform you that your credibility has severely diminished and most of what you guys post are just black lines on a white canvas. Words that my form sentences but have no true meaning. The 4 Amigos have fallen into a giant worm hole and are speaking from an alternative universe. Have your fun. We are getting enjoyment from these posts and know that if what was being posted was valid or had any merit whatsoever, then the "REAL SHAREHOLDERS" would and could ask Dr Moro directly. The fireworks will be lit at the ISOBM where Dr Moro will be introduced by the Chairman of the ISOBM, Dr. Steward Sell, who happens to be a member of our scientific board. Do think he would agree to joining the team at BioCurex if it were a sham?
By the way. It is a real shocker that you are in agreement with Ted.
There is much more to the story of the 4 Amigos than their self-described obligation to "save us." Recaf also detects bull**** and right now we are getting 100% specificity and 100% sensitivity.
"I am also concerned about" ....GS, what are you concerned about if you sold? I just don't get it.
Hmmmm....DC STEVE now ZO LAX??????
What is your motivation for being here if you just admitted to having sold your shares? I have invested without exagerating over a hundred plus companies over the years and some I take profits, and some I take losses, but I move on. When I am not holding shares I move onto a new investment idea. BioCurex and my stem cell stocks are my only speculative stocks. I have hope they will both succeed. I will admit that I may have invested a bit early in both, but the technology is moving forward and is soon to become a reality.
Normally, I am known to have little patience, but this will IMO change medicine in general.
Be very careful when you say factual loosely, however, if you are a shareholder you must be bipolar.
For example, if you were a Yahoo shareholder (which I hope no one here is) would you keep repeating that Google is far superior and Yahoo does not have a chance to survive? The logic does not add up. I like the transparency, because I can see right thru the 4 Amigos. Good luck with your mission to loose money.
This is boring me to sleep. Good night.
If Dr Moro is saying he will be using ADML as a precedent, he must be getting ready present to the FDA. He has been in discussions as he stated and feels we should not have a problem satisfying the FDA, because he was shocked at how low the bar has been set with their rediculous results previouly presented.
You saw how fast he developed the ELISA test, and Dr Wittenberg claims he expects royalties shortly. We most definitely will trigger royalties upon FDA approval. It is time to refocus on the application process.
This is the most likely scenario, but Ted don't blow a fuse if it blows up your theory of doom and gloom.
Dr Moro had been working on Recaf and assumed that it would be a 50/50 team approach with Abbott, but Abbott was stumbling in the lab and the heavy lifting was done by BioCurex. Dr Moro's intricate knowledge of Recaf led him to overcome several major hurdles and while he was feverishly working in the lab and attaining great success he was working with Inverness.
Obviously, Recaf was getting great results on the automated instruments and Dr Moro knew he had created much more leverage since his original agreement with Abbott so he was able to get a commitment with upfront royalties from Inverness. Meanwhile, we all know chaos broke out at Abbott and Dr Moro again used his leverage torenegotiate terms with Abbott following his success with Inverness. The entire time all of this was transpiring Dr Moro was scrambling to get new patents and was successful in Europe.
How you can say Dr Moro had the license returned is beyond me. Inverness is a large competitor. Do you honestly think that Abbott would just roll over and let Inverness monopolize the cancer diagnostics market. Think about it. Now look at the results presented at the ISOBM in conjunction with Abbott how could they explain to their shareholders that they had good reason to return the license. Also, read the press release about the new terms Dr Moro initiated, not Abbott, and you will see his confidence was raised when he was successful with Inverness and with his continued success in the lab. Dr Moro wants maximum royalties, because he has the patents and the know-how, not Abbott. There was no return, so stop spreading untrue rumors.
If we don't see you post at Agora you are all cooked and this charade has officially ended today. Dr Moro can't defend himself here, but I will.
As of late, we are definitely beginning to see the true colors of some the posters on this board. Agora speaks truthfully. Here we have a bunch of speculators and fearmongers. I bet some of you may work for one of those competitors Gold just posted. What's the matter? Do our new patents scare you? Kag, have you anything positive to say or are casting stones your sole purpose in posting here. Try posting your comments at Agora or are you afraid of the truth? If you have a shred of character you will not hide behind an alias to ask your questions or pose your concerns. If you don't you will forfeit any credibility and should no longer be heard from again. I am calling you out. CHECK MATE! If we don't see you or Gold ever post at Agora or you have some excuse for not posting I will continue to pose thequestion till you do, so let's put an end to this TODAY!